Fast-twitch sarcomeric and glycolytic enzyme protein loss in inclusion body myositis

Muscle and Nerve

Volumn 39, Issue 6, 2009, Pages 739-753

  Parker, Kenneth C ^a,b   Sek, Won Kong ^c   Walsh, Ronan J ^b,c   Salajegheh, Mohammad ^b,c   Moghadaszadeh, Behzad ^c   Amato, Anthony A ^b   Nazareno, Remedios ^b,c   Yin, Yin Lin ^c   Krastins, Bryan ^a   Sarracino, David A ^a   Beggs, Alan H ^c   Pinkus, Jack L ^b,c   Greenberg, Steven A ^b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Dermatomyositis; Inclusion body myositis; Inflammatory myopathies; Polymyositis; Proteomics

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CALPAIN 3; GLYCOGEN DEBRANCHING ENZYME; GLYCOLYTIC ENZYME; IMMUNOGLOBULIN; MEMBRANE PROTEIN;

ARTICLE; CLINICAL ARTICLE; FAST MUSCLE; FEMALE; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INCLUSION BODY MYOSITIS; INFLAMMATION; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MICROARRAY ANALYSIS; MUSCLE ATROPHY; MUSCLE BIOPSY; MYOPATHY; NEUROMUSCULAR DISEASE; POLYMYOSITIS; PRIORITY JOURNAL; PROTEIN DEPLETION; SARCOMERE; SKELETAL MUSCLE;

ACTININ; ADULT; AGED; BIOPSY; CALPAIN; CHROMATOGRAPHY, LIQUID; DOWN-REGULATION; ENZYMES; GLYCOGEN STORAGE DISEASE TYPE III; GLYCOLYSIS; HUMANS; MASS SPECTROMETRY; MIDDLE AGED; MUSCLE FIBERS, FAST-TWITCH; MUSCLE PROTEINS; MUSCLE, SKELETAL; MYOSIN HEAVY CHAINS; MYOSITIS, INCLUSION BODY; NUCLEAR ENVELOPE; PROTEOMICS; RNA, MESSENGER; SARCOMERES;

EID: 67049165108     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21230     Document Type: Article

References (42)

1. Arnardottir S, Borg K, Ansved T. Sporadic inclusion body myositis: morphology, regeneration, and cytoskeletal structure of muscle fibres. J Neurol Neurosurg Psychiatry 2004;75:917-920. (Pubitemid 38658523)
2. Askanas V, Sarkozi E, Bilak M, Alvarez RB, Engel WK. Human muscle macrophages express beta-amyloid precursor and prion proteins and their mRNAs. Neuroreport 1995;6:1045-1049.
3. Askanas V, Serratrice G, Engel WK. Inclusion-body myositis and myopathies. New York: Cambridge University Press; 1998.
4. Banwell BL, Engel AG. AlphaB-crystallin immunolocalization yields new insights into inclusion body myositis. Neurology 2000;54:1033-1041. (Pubitemid 30151842)
5. Bradshaw EM, Orihuela A, McArdel SL, Salajegheh M, Amato AA, Hafler DA, et al. A local antigen-driven humoral response is present in the inflammatory myopathies. J Immunol 2007;178:547-556. (Pubitemid 46033639)
6. Chan Y, Tong HQ, Beggs AH, Kunkel LM. Human skeletal muscle-specific alpha-actinin-2 and-3 isoforms form homodimers and heterodimers in vitro and in vivo. Biochem Biophys Res Commun 1998;248:134-139. (Pubitemid 28418200)
7. Choi YC, Park GT, Kim TS, Sunwoo IN, Steinert PM, Kim SY. Sporadic inclusion body myositis correlates with increased expression and cross-linking by transglutaminases 1 and 2. J Biol Chem 2000;275:8703-8710. (Pubitemid 30180222)
8. Dalakas MC, Koffman B, Fujii M, Spector S, Sivakumar K, Cupler E. A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM. Neurology 2001;56:323-327. (Pubitemid 32144142)
9. Engel WK, Askanas V. Inclusion-body myositis: clinical, diagnostic, and pathologic aspects. Neurology 2006;66(2 Suppl 1):S20-29. (Pubitemid 43739980)
10. Figarella-Branger D, Pellissier JF, Bianco N, Devictor B, Toga M. Inflammatory and non-inflammatory inclusion body myositis. Characterization of the mononuclear cells and expression of the immunoreactive class I major histocompatibility complex product. Acta Neuropathol 1990;79:528-536.
11. Gelfi C, Vigano A, Ripamonti M, Pontoglio A, Begum S, Pellegrino MA, et al. The human muscle proteome in aging. J Proteome Res 2006;5:1344-1353. (Pubitemid 43865805)
12. Gonzalez-Billault C, Del Rio JA, Urena JM, Jimenez-Mateos EM, Barallobre MJ, Pascual M, et al. A role of MAP1B in Reelin-dependent neuronal migration. Cereb Cortex 2005;15:1134-1145. (Pubitemid 41373606)
13. Greenberg SA, Bradshaw EM, Pinkus JL, Pinkus GS, Burleson T, Due B, et al. Plasma cells in muscle in inclusion body myositis and polymyositis. Neurology 2005;65:1782-1787. (Pubitemid 43754412)
14. Greenberg SA, Pinkus JL, Pinkus GS, Burleson T, Sanoudou D, Tawil R, et al. Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis. Ann Neurol 2005;57:664-678. (Pubitemid 40628855)
15. Greenberg SA, Pinkus JL, Amato AA. Nuclear membrane proteins are present within rimmed vacuoles in inclusion-body myositis. Muscle Nerve 2006;34:406-416. (Pubitemid 44506707)
16. Greenberg SA. Comment on 'Interrelation of inflammation and APP in sIBM: IL-1{beta} induces accumulation of {beta}- amyloid in skeletal muscle.' Brain 2008 (to be published).
17. Griggs RC, Askanas V, DiMauro S, Engel A, Karpati G, Mendell JR, et al. Inclusion body myositis and myopathies. Ann Neurol 1995;38:705-713.
18. Hojlund K, Yi Z, Hwang H, Bowen B, Lefort N, Flynn CR, et al. Characterization of the human skeletal muscle proteome by one-dimensional gel electrophoresis and HPLC-ESI-MS/MS. Mol Cell Proteomics 2008;7:257-267. (Pubitemid 351298440)
19. Hoogendijk JE, Amato AA, Lecky BR, Choy EH, Lundberg IE, Rose MR, et al. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscul Disord 2004;14:337-345.
20. Huang Y, de Morree A, van Remoortere A, Bushby K, Frants RR, Dunnen JT, et al. Calpain 3 is a modulator of the dysferlin protein complex in skeletal muscle. Hum Mol Genet 2008;17:1855-1866. (Pubitemid 351791513)
21. Hutchinson DO, Jongbloed B. Two-dimensional gel electrophoresis in inclusion body myositis. J Clin Neurosci 2008;15:440-444.
22. Ishihama Y, Oda Y, Tabata T, Sato T, Nagasu T, Rappsilber J, et al. Exponentially modified protein abundance index (em- PAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics 2005;4:1265-1272. (Pubitemid 41448714)
23. Jin S, Daly DS, Springer DL, Miller JH. The effects of shared peptides on protein quantitation in label-free proteomics by LC/MS/MS. J Proteome Res 2008;7:164-169. (Pubitemid 351171128)
24. Karpati G, Hilton-Jones D, Griggs RC. Disorders of voluntary muscle. New York: Cambridge University Press; 2001.
25. Leclerc A, Tome FM, Fardeau M. Ubiquitin and beta-amyloid-protein in inclusion body myositis (IBM), familial IBM-like disorder and oculopharyngeal muscular dystrophy: an immunocytochemical study. Neuromuscul Disord 1993;3:283-291. (Pubitemid 23345044)
26. Li J, Yin C, Okamoto H, Jaffe H, Oldfield EH, Zhuang Z, et al. Proteomic analysis of inclusion body myositis. J Neuropathol Exp Neurol 2006;65:826-833. (Pubitemid 44200323)
27. Mikol J, Engel A. Inclusion body myositis. Myology. 3rd ed. In: Engel AG, Franzini-Armstrong C, editors. Volume 2. New York: McGraw-Hill; 2004.
28. Nalbantoglu J, Karpati G, Carpenter S. Conspicuous accumulation of a single-stranded DNA binding protein in skeletal muscle fibers in inclusion body myositis. Am J Pathol 1994;144:874-882. (Pubitemid 24160628)
29. North KN, Yang N, Wattanasirichaigoon D, Mills M, Easteal S, Beggs AH. A common nonsense mutation results in alpha-actinin- 3 deficiency in the general population. Nat Genet 1999;21:353-354. (Pubitemid 29159565)
30. Nukina N, Kosik KS, Selkoe DJ. Recognition of Alzheimer paired helical filaments by monoclonal neurofilament antibodies is due to crossreaction with tau protein. Proc Natl Acad Sci U S A 1987;84:3415-3419. (Pubitemid 17085414)
31. Parker KC, Patterson D, Williamson B, Marchese J, Graber A, He F, et al. Depth of proteome issues: a yeast isotope-coded affinity tag reagent study. Mol Cell Proteomics 2004;3:625-659. (Pubitemid 39076998)
32. Patterson SD, Aebersold R. Mass spectrometric approaches for the identification of gel-separated proteins. Electrophoresis 1995;16:1791-1814.
33. Preedy VR, Peters TJ. Skeletal muscle: pathology, diagnosis, and management of disease. London: Greenwich Medical Media; 2002.
34. Sarkozi E, Askanas V, Johnson SA, McFerrin J, Engel WK. Expression of beta-amyloid precursor protein gene is developmentally regulated in human muscle fibers in vivo and in vitro. Exp Neurol 1994;128:27-33. (Pubitemid 24278362)
35. Schapira AHV, Griggs RC. Muscle diseases. Boston: Butterworth- Heinemann; 1999.
36. Schmidt J, Barthel K, Wrede A, Salajegheh M, Bahr M, Dalakas MC. Interrelation of inflammation and APP in sIBM: IL-1 beta induces accumulation of beta-amyloid in skeletal muscle. Brain 2008;131(Pt 5):1228-1240.
37. Sherriff FE, Joachim CL, Squier MV, Esiri MM. Ubiquitinated inclusions in inclusion-body myositis patients are immunoreactive for cathepsin D but not beta-amyloid. Neurosci Lett 1995;194:37-40.
38. Taveau M, Bourg N, Sillon G, Roudaut C, Bartoli M, Richard I. Calpain 3 is activated through autolysis within the active site and lyses sarcomeric and sarcolemmal components. Mol Cell Biol 2003;23:9127-9135. (Pubitemid 37499802)
39. Verma A, Bradley WG, Soule NW, Pendlebury WW, Kelly J, Adelman LS, et al. Quantitative morphometric study of muscle in inclusion body myositis. J Neurol Sci 1992;112:192-198.
40. Washburn MP, Ulaszek RR, Yates JR 3rd. Reproducibility of quantitative proteomic analyses of complex biological mixtures by multidimensional protein identification technology. Anal Chem 2003;75:5054-5061.
41. Weigum SE, Garcia DM, Raabe TD, Christodoulides N, Koke JR. Discrete nuclear structures in actively growing neuroblastoma cells are revealed by antibodies raised against phosphorylated neurofilament proteins. BMC Neurosci 2003;4:6. (Pubitemid 38729173)
42. Zatloukal K, Stumptner C, Fuchsbichler A, Heid H, Schnoelzer M, Kenner L, et al. p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases. Am J Pathol 2002;160:255-263. (Pubitemid 34052286)